Valuation Scienture Holdings, Inc.

Stocks

Market Closed - Nasdaq 07:00:00 30/10/26 am AEDT			5-day change	1st Jan Change
3.490 ^USD	+2.65%		+20.14%	-72.63%

29/10	Scienture Holdings, Inc. - Shareholder/Analyst Call
13/10	Scienture Holdings, Inc. Reports Preliminary, Unaudited Revenue Results for the Third Quarter Ended September 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2024	2025	2026	2027	2028
Market Cap ¹	52.94	20.72	5.585	-	-
Change	-	-60.86%	-73.05%	-	-
Enterprise Value (EV)	52.94	20.72	5.585	5.585	5.585
Change	-	-60.86%	-73.05%	0%	0%
P/E	2.25x	-0.19x	-0.79x	-13x	3.21x
PBR	-	-	-	-	-
PEG	-	0x	0x	0.1x	-0x
Capitalization / Revenue	-	48x	1.53x	0.36x	0.16x
EV / Revenue	-	0x	1.53x	0.36x	0.16x
EV / EBITDA	-	-	-	-	-
EV / EBIT	-	-0x	-0.54x	-5.87x	0.45x
EV / FCF	-	-	-	-	-
FCF Yield	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-
Rate of return	-	-	-	-	-
EPS ²	67.25	-67.5	-4.44	-0.27	1.09
Distribution rate	-	-	-	-	-
Net sales ¹	-	0.4316	3.64	15.47	35.2
EBITDA	-	-	-	-	-
EBIT ¹	-	-42.59	-10.41	-0.952	12.31
Net income ¹	9.066	-41.51	-10.43	-1.262	9.599
Net Debt	-	-	-	-	-
Reference price ²	151.250	12.750	3.500	3.500	3.500
Nbr of stocks (in thousands)	350	1,625	1,643	-	-
Announcement Date	26/3/25	30/3/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SCIENTURE HOLDINGS, INC.	-0.77x	-	-	-	5.58M
ELI LILLY AND COMPANY	37.84x	13.27x	28.43x	0.53%	1,148B
JOHNSON & JOHNSON	39.67x	6.67x	18.75x	1.97%	652B
ABBVIE INC.	37.4x	8.39x	17.35x	2.4%	505B
ROCHE HOLDING AG	21.45x	5.21x	12.93x	2.51%	384B
MERCK & CO., INC.	102.73x	5.76x	24.72x	2.42%	348B
NOVARTIS AG	21.89x	5.76x	13.88x	2.85%	294B
ASTRAZENECA PLC	22.21x	4.49x	12.82x	1.97%	264B
AMGEN INC.	28.66x	7.33x	13.12x	2.23%	244B
GILEAD SCIENCES, INC.	-45.79x	7.11x	27.55x	2.07%	197B
Average	26.53x	7.11x	18.84x	2.11%	403.72B
Weighted average by Cap.	35.29x	8.40x	20.64x	1.79%